Unmeasurable Stimulated Thyroglobulin Before Radioactive Iodine Ablation Predicts Excellent Long-Term Outcomes in Patients with Differentiated Thyroid Cancer
Cancers · 25.03.2026 · 18 (7) · 1058
DOI: 10.3390/cancers18071058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 25.03.2026. Verfasst von Yi Sia und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine Surgery, Churchill Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
There is ongoing interest in limiting the extent of treatment for patients with low-risk differentiated thyroid cancer (DTC) and in redesigning individualised follow-up strategies. This study assessed long-term outcomes in patients with excellent response to surgical treatment demonstrated by reaching unmeasurable stimulated thyroglobulin (sTG) levels before proceeding with radioactive iodine ablation.
Methods
This is a retrospective cohort study of consecutive patients treated for DTC in a tertiary referral centre. Radioactive iodine ablation (RIA) was done after hormone withdrawal (before 2015) or after Thyrogen stimulation (in recent years). The biochemical assay for TG changed from a lower limit of detectability of 5 ng/mL to 0.2 ng/mL in 2012.
Results
Of 331 patients operated on between 2001 and 2019, unmeasurable sTG was measured in 70 of 138 patients (51%) when using an assay with threshold of 5 ng/mL and in 38 of 193 patients (20%) based on the threshold of 0.2 ng/mL. Compared with patients whose sTG was >5 ng/mL, those with sTG
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrine Surgery, Churchill Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.
ORCID-Profile: Radu Mihai
Zitieren
APA
Sia, Y., & Mihai, R. (2026). Unmeasurable Stimulated Thyroglobulin Before Radioactive Iodine Ablation Predicts Excellent Long-Term Outcomes in Patients with Differentiated Thyroid Cancer. Cancers, 18(7), 1058. https://doi.org/10.3390/cancers18071058
Vancouver
Sia Y, Mihai R. Unmeasurable Stimulated Thyroglobulin Before Radioactive Iodine Ablation Predicts Excellent Long-Term Outcomes in Patients with Differentiated Thyroid Cancer. Cancers. 2026;18(7):1058. doi:10.3390/cancers18071058
BibTeX
@article{Sia2026,
author = {Sia, Yi and Mihai, Radu},
title = {Unmeasurable Stimulated Thyroglobulin Before Radioactive Iodine Ablation Predicts Excellent Long-Term Outcomes in Patients with Differentiated Thyroid Cancer},
journal = {Cancers},
year = {2026},
volume = {18},
number = {7},
pages = {1058},
doi = {10.3390/cancers18071058}
}
EUVIMED